Showing results (431-440 of 567) with videos related to

Sort By:
Pageof 57
The Pediatric Infectious Disease Journal|May 29, 2007
Determination of extended-interval gentamicin dosing for neonatal patients in developing countriesGary L Darmstadt, M Monir Hossain, Atanu Kumar Jana, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 27, 2022
Androgen deprivation therapy for prostate cancer: Prescribing behaviors and preferences among urologistsDouglas C Cheung, Lisa J Martin, Shabbir M H Alibhai, et al.
Diabetes, Obesity & Metabolism|September 2, 2024
Effects of ertugliflozin on uric acid and gout-related outcomes in persons with type 2 diabetes and cardiovascular disease: Post hoc analyses from VERTIS CVVikas S Sridhar, Francesco Cosentino, Samuel Dagogo-Jack, et al.
Diagnostic Microbiology and Infectious Disease|December 22, 2017
Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza virusesJ H Chen, H Y Lam, C C Yip, et al.
The Journal of Urology|March 6, 2014
The importance of surgeon characteristics on impacting oncologic outcomes for patients undergoing radical cystectomyBimal Bhindi, Julie Yu, Cynthia Kuk, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2014
Abiraterone acetate in metastatic castration-resistant prostate cancer: a retrospective review of the Princess Margaret experience of (I) low dose abiraterone and (II) prior ketoconazoleRaya Leibowitz-Amit, Jo-An Seah, Eshetu G Atenafu, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Acid suppression in healthy subjects following lansoprazole or pantoprazoleJ-Q Huang, D R Goldwater, A B R Thomson, et al.
Head & Neck|September 4, 2003
Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: a multicenter, randomized, double-blind, phase III study in North AmericaDan J Castro, Kasi S Sridhar, Harinder S Garewal, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|November 20, 2014
Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologistsTina Hsu, Peter C Black, Kim N Chi, et al.
Cancer Chemotherapy and Pharmacology|July 6, 2010
A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancerSrikala S Sridhar, Christina M Canil, Kim N Chi, et al.
Pageof 57